Related Experiment Video
Updated: May 25, 2025

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.4K
Self-medication practices in Ethiopia: An umbrella review protocol
Getahun Fetensa1,2,3, Eshetu Ejeta4, Tariku Tesfaye Bekuma5,6
1Department of Health Behavior and Society, Faculty of Public Health, Institute of Health, Jimma Medical Center, Jimma University, Jimma, Ethiopia.
Plos One
|February 27, 2025
Summary
This review examines self-medication practices in Ethiopia, highlighting its health and economic impacts. Findings will inform interventions to combat antimicrobial resistance and improve public health.
Area of Science:
- Public Health
- Pharmacology
- Systematic Review Methodology
Background:
- Self-medication, the use of drugs without professional guidance, poses significant health and economic risks.
- It is a prevalent issue with potential to exacerbate public health challenges.
Purpose of the Study:
- To systematically review and synthesize existing evidence on self-medication practices among adults in Ethiopia.
- To identify patterns and factors associated with self-medication to inform targeted interventions.
Main Methods:
- An umbrella review methodology was employed, focusing on systematic reviews.
- Searches were conducted in MEDLINE, Embase, and Cochrane Database of Systematic Reviews.
- Data extraction and quality appraisal were performed by two independent reviewers using the JBI critical appraisal checklist.
Main Results:
- The review will synthesize data on self-medication practices across various Ethiopian populations.
- Extracted data will include study characteristics, patient demographics, and reported self-medication behaviors.
- Quality of included systematic reviews will be assessed to ensure reliability of findings.
Conclusions:
- The synthesized evidence aims to provide a comprehensive understanding of self-medication in Ethiopia.
- Findings will guide the development of interventions to mitigate risks, particularly concerning antimicrobial resistance.
- The review underscores the need for governmental and non-governmental action in resource-limited settings.
More Related Videos
Related Concept Videos
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drugs for Treatment of Diarrhea-Predominant IBS
139
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
139

